BCL9/BCL9L promotes tumorigenicity through immune-dependent and independent mechanisms in triple negative breast cancer.
Wang X, Feng M, Xiao T, Guo B, Liu D, Liu C, Pei J, Liu Q, Xiao Y, Rosin-Arbesfeld R, Shi Y, Zhou Y, Yang M, Feng YX, Jiang Y, Shao Z, Yu K, Zhu D.
Wang X, et al.
Oncogene. 2021 Apr;40(16):2982-2997. doi: 10.1038/s41388-021-01756-y. Epub 2021 Mar 25.
Oncogene. 2021.
PMID: 33767438